CVS Eye Drops Class Action Settlement

The CVS Eyedrops Class Action alleges that CVS sold Similasan homeopathic eye drops under its CVS Health brand, which didn’t work as advertised. The lawsuit says CVS claimed the products could treat symptoms like red, dry, or itchy eyes, but they may not actually do what the labels promised. CVS denies any wrongdoing but agreed to pay $1 million to settle the case.

Who Qualifies for a Payout in This Settlement?

If you bought certain CVS-brand Similasan homeopathic eye drops in the U.S. between March 8, 2018, and June 12, 2024, you may be eligible for money from this settlement. Products include:

  • CVS Health Pink Eye Relief
  • CVS Health Dry Eye Relief
  • CVS Health Allergy Eye Relief

You can check the full list of eligible products at the settlement website.

Is It Necessary to Provide Proof (or Proof of Purchase)?

You don’t need proof to file a claim.

  • If you don’t have a receipt, you can still file a claim for up to 2 products.
  • If you do have receipts, you can claim for all the products you bought.

What Amount Can I Receive from This Settlement?

You can get up to $5 for each product:

  • Without receipts: You can get money for up to 2 products (maximum $10 total).
  • With receipts: You can claim for as many products as you purchased, with no limit.

The final amount may change depending on how many people file claims.

How Can I Submit My Claim?

There are two ways to file your claim:

  1. Online: Fill out the form at the official website.
  2. By Mail: Print and fill out the claim form, then mail it to: CVS Eyedrops Settlement Administrator
    P.O. Box 58220
    Philadelphia, PA 19102

You can choose to get your payment by check or digital payment.

Important Dates

  • Deadline to file a claim: August 8, 2024
  • Deadline to exclude yourself or object: August 8, 2024
  • Final court approval hearing: September 5, 2024

Payments will be sent after the court gives final approval and any appeals are resolved.

To file your claim or learn more, visit the official site now.